OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 50 filers reported holding OMEGA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 139 | 0.0% | 0.00% | – |
Q2 2023 | $1 | 0.0% | 139 | 0.0% | 0.00% | – |
Q1 2023 | $1 | 0.0% | 139 | 0.0% | 0.00% | – |
Q4 2022 | $1 | -99.9% | 139 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 139 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 139 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 139 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | – | 139 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 352,941 | $6,653,000 | 8.31% |
CHI Advisors LLC | 1,055,882 | $19,904,000 | 5.81% |
Flagship Pioneering Inc. | 25,902,269 | $488,258,000 | 5.11% |
HARBOURVEST PARTNERS LLC | 2,647,059 | $49,897,000 | 4.69% |
Octagon Capital Advisors LP | 370,279 | $6,980,000 | 1.72% |
Monashee Investment Management LLC | 441,176 | $8,316,000 | 1.54% |
Artal Group S.A. | 2,273,530 | $42,856,000 | 0.96% |
SPHERA FUNDS MANAGEMENT LTD. | 527,948 | $9,952,000 | 0.84% |
PLATINUM INVESTMENT MANAGEMENT LTD | 500,000 | $9,425,000 | 0.26% |
Logos Global Management LP | 88,235 | $1,663,000 | 0.12% |